Literature DB >> 22526474

Evaluation of 20 years experience of fibrodysplasia ossificans progressiva in Iran: lessons for early diagnosis and prevention.

Seyed Reza Raees-Karami1, Hanieh Jafarieh, Vahid Ziyayi, Reza Shekarriz Foumani, Yahya Aghighi.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare genetic inflammatory disorder characterized by progressive heterotopic ossification presenting as recurrent soft tissue masses and swelling which may cause disabling, restricted joint mobility. Congenital malformations of the hallux are characteristic features of classic FOP, predating the appearance of disabling features. As no definite treatment is available, the early diagnosis and prevention of exacerbating factors may lead to significant benefits in terms of the life quality of patients. A retrospective study of 12 consecutive FOP patients referred to and admitted in the rheumatology unit at an urban tertiary care academic center between 1991 and 2011. Data, such as age, gender, and past medical history, were collected from the medical history, physical examination, and skeletal survey in order to characterize the clinical presentations. All 12 children (six boys and six girls; ages 2.0-13.5 years) had congenital malformations of the great toes (microdactyly and hallux valgus deformity), in addition to heterotopic ossification presenting as multiple soft tissue tumor-like swellings. Spinal involvement, most notably in the cervical region, suggestive of an early FOP, was present in 83.3 %. Eleven patients (91.6 %) had a prior history of direct physical trauma, while 7 of 11 (63.6 %) had undergone invasive diagnostic procedures, both correlating with the exacerbations of their condition. Clinical awareness of fibrodysplasia ossificans progressiva and its early diagnostic features, particularly congenital malformations of the hallux, during a thorough neonatal examination may lead to an early diagnosis preventing the development of disabling, practically irreversible lesions of heterotopic ossification. Genetic and molecular studies can play a considerable role in the diagnosis of FOP in suspected cases. Early institution of prophylactic and precautionary measures, such as categorical avoidance of trauma and invasive procedures, can significantly reduce the debilitating acute exacerbations of the condition.

Entities:  

Mesh:

Year:  2012        PMID: 22526474     DOI: 10.1007/s10067-012-1968-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Genetic testing of children for adult-onset diseases: is testing in the child's best interests?

Authors:  Mary Kay Pelias
Journal:  Mt Sinai J Med       Date:  2006-05

2.  Disclosing individual genetic results to research participants.

Authors:  Vardit Ravitsky; Benjamin S Wilfond
Journal:  Am J Bioeth       Date:  2006 Nov-Dec       Impact factor: 11.229

3.  A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.

Authors:  Eileen M Shore; Meiqi Xu; George J Feldman; David A Fenstermacher; Tae-Joon Cho; In Ho Choi; J Michael Connor; Patricia Delai; David L Glaser; Martine LeMerrer; Rolf Morhart; John G Rogers; Roger Smith; James T Triffitt; J Andoni Urtizberea; Michael Zasloff; Matthew A Brown; Frederick S Kaplan
Journal:  Nat Genet       Date:  2006-04-23       Impact factor: 38.330

4.  Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway.

Authors:  Alyssa A Schaffer; Frederick S Kaplan; Michael R Tracy; Megan L O'Brien; John P Dormans; Eileen M Shore; Richard M Harland; Kenro Kusumi
Journal:  Spine (Phila Pa 1976)       Date:  2005-06-15       Impact factor: 3.468

5.  The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. A study of forty-four patients.

Authors:  R B Cohen; G V Hahn; J A Tabas; J Peeper; C L Levitz; A Sando; N Sando; M Zasloff; F S Kaplan
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

6.  Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva.

Authors:  F S Kaplan; C M Strear; M A Zasloff
Journal:  Clin Orthop Relat Res       Date:  1994-07       Impact factor: 4.176

7.  Fibrodysplasia ossificans progressiva.

Authors:  S Mahboubi; D L Glaser; E M Shore; F S Kaplan
Journal:  Pediatr Radiol       Date:  2001-05

8.  Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Sharon Kantanie; David M Rocke; Frederick S Kaplan
Journal:  Pediatrics       Date:  2005-10-17       Impact factor: 7.124

9.  Age- and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva.

Authors:  D M Rocke; M Zasloff; J Peeper; R B Cohen; F S Kaplan
Journal:  Clin Orthop Relat Res       Date:  1994-04       Impact factor: 4.176

10.  The histopathology of fibrodysplasia ossificans progressiva. An endochondral process.

Authors:  F S Kaplan; J A Tabas; F H Gannon; G Finkel; G V Hahn; M A Zasloff
Journal:  J Bone Joint Surg Am       Date:  1993-02       Impact factor: 5.284

  10 in total
  4 in total

1.  The phenotype and genotype of fibrodysplasia ossificans progressiva in China: a report of 72 cases.

Authors:  Wei Zhang; Keqin Zhang; Lige Song; Jing Pang; Hongxing Ma; Eileen M Shore; Frederick S Kaplan; Peijun Wang
Journal:  Bone       Date:  2013-09-17       Impact factor: 4.398

2.  Clinical and Genetic Analysis of Fibrodysplasia Ossificans Progressiva: A Case Report and Literature Review.

Authors:  Maheshwar Lakkireddy; Vijaykrishna Chilakamarri; Prajnya Ranganath; Abhishek Jagdishchander Arora; Maria Celestina Vanaja
Journal:  J Clin Diagn Res       Date:  2015-08-01

3.  FOP: still turning into stone.

Authors:  Reza Taslimi; Saba Jafarpour; Nahid Hassanpour
Journal:  Clin Rheumatol       Date:  2013-11-20       Impact factor: 2.980

4.  Quality of life of patients with fibrodysplasia ossificans progressiva.

Authors:  Fernando Ortiz-Agapito; Douglas Colmenares-Bonilla
Journal:  J Child Orthop       Date:  2015-11-13       Impact factor: 1.548

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.